Form 4 for IDXX Idexx Laboratories
Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-17 · accession 0000874716-26-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-19 | 2026-02-17 | IDXX | Vandebroek Sophie V. | Dir | M - OptEx | $333.90 | +945 | 2,112 | +81% | +$315.5K |
| DM | 2026-02-19 | 2026-02-17 | IDXX | Vandebroek Sophie V. | Dir | S - Sale+OE | $628.62 | -1,464 | 648 | -69% | -$920.3K |
| D | 2026-02-19 | 2026-02-17 | IDXX | Vandebroek Sophie V. | Dir | M - OptEx | — | -945 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-17 | M | A | 945 | $333.90 | 2,112 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-17 | S | D | 945 | $628.65 | 1,167 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-17 | S | D | 519 | $628.56 | 648 | D | — | — | |
| 4 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2026-02-17 | M | D | 945 | — | 0 | D | $333.90 · — to 2032-05-10 | 945 Common Stock | (F2) Not applicable (F1) Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of stockholders, whichever event was earlier. |